share_log

GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Transcript Summary

GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Transcript Summary

GoHealth, Inc.(GOCO)2024年第三季度業績會電話交流摘要
富途資訊 ·  11/09 17:42  · 電話會議

The following is a summary of the GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Transcript:

以下是gohealth, Inc. (GOCO)2024年第三季度業績會文本摘要:

Financial Performance:

財務業績:

  • GoHealth reported Q3 2024 net revenues of $118.3 million, a decrease from $132 million in Q3 2023.

  • Internal captive agent submissions increased by 46% year-over-year due to enhanced training and technology.

  • Adjusted EBITDA for the quarter was negative $12.1 million, slightly down by $600,000 compared to the prior year.

  • gohealth報告2024年第三季度營業收入爲11830萬美元,較2023年第三季度的13200萬美元有所下降。

  • 由於加強培訓和科技,內部全職代理商提交量同比增長46%。

  • 本季度調整後的EBITDA爲負1210萬美元,與去年同期相比略有下降,減少了60萬美元。

Business Progress:

業務進展:

  • Completed the acquisition of e-TeleQuote, contributing significantly to net income.

  • Refinanced the term loan credit facility which strengthens financial stability and supports growth.

  • Introduced PlanFit CheckUp and PlanFit Save, enhancing the Medicare shopping experience and focusing on relationship building with health plan partners.

  • 完成了收購e-TeleQuote,大幅貢獻了淨利潤。

  • 重新融資了期限貸款信貸工具,增強了財務穩定性並支持增長。

  • 推出PlanFit CheckUp和PlanFit Save,增強Medicare購物體驗,並專注於與健康計劃夥伴的關係建設。

Opportunities:

機會:

  • Acquisition of e-TeleQuote brought nearly 400 licensed agents, enhancing agent capacity and operational capabilities.

  • Anticipate positive market conditions through the first three quarters of 2025, driving sustained growth.

  • 收購e-TeleQuote公司帶來近400名持牌代理人,增強代理能力和運營能力。

  • 預計2025年前三個季度市場條件將積極,推動持續增長。

Risks:

風險:

  • Suffered an $8.8 million revenue reduction and a $7.8 million earnings impact due to a cyber-attack on Change Healthcare, affecting Medicaid eligibility assessments.

  • 由於Change Healthcare遭受網絡攻擊,影響了Medicaid資格評估,導致880萬美元營業收入減少和780萬美元淨利潤影響。

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:如需更全面的詳情,請參閱投資人關係網站。本文僅供投資者參考,不作任何指引或建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論